Channels - Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice :: FRELIP Discovery

Similar Items: Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice

Quick Look
Prediction of incident heart failure in type 2 diabetes mellitus: Rationale and design of the DM‐HEART study
Quick Look
Methodological considerations on the associations of serum CTRP3 and CysC with bone metabolism in elderly patients with T2DM
Quick Look
Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
Quick Look
Recent advances in pancreatic β‐cell dysfunction in type 2 diabetes mellitus: Intracellular stress and dedifferentiation
Quick Look
Left ventricular strain and chamber dimensions in pediatric sickle cell disease: age-related reduction in myocardial deformation independent of hemolysis and hydroxyurea therapy
Quick Look
Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross‐sectional study
Quick Look
Waist‐to‐height ratio and renal dysfunction as independent correlates of low handgrip strength in patients with type 2 diabetes
Quick Look
Global burden of metabolic dysfunction-associated steatotic liver disease attributable to tobacco, 1990–2023, and projected trends to 2038
Quick Look
Letter to the Editor in response to “Association between thyroid dysfunction and cognitive impairment in type 2 Diabetes Mellitus: A cross‐sectional study”
Quick Look
Letter to the Editor in response to the article “Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross‐sectional study”
Quick Look
Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study
Quick Look
Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?
Quick Look
Neuregulin 4‐dependent MAPK amplification mediates urate‐induced β‐cell dysfunction
Quick Look
Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis
Quick Look
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
Quick Look
Trends in the incidence and prevalence of thyroid dysfunction over 18 years and projections for 2030: the Tehran thyroid study
Quick Look
Assessment of plasma glycated CD59 in type 2 diabetic patients with diabetic retinopathy and nephropathy: a study of combined microvascular complications
Quick Look
Improving the predictive value of end-of-treatment PET/ CT in diffuse large B-cell lymphoma
Quick Look
Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities
Quick Look
Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India
Quick Look
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal
Quick Look
Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options
Quick Look
Clarification of poor adherence to treatment among patients with type 2 diabetes in Iran: the magnitude of the problem and the its determinants
Quick Look
Association of Sodium‐Glucose Cotransporter 2 Inhibitors Treatment With Contrast‐Induced Acute Kidney Injury in Older Adults With T2D and CKD: A Propensity Matched Analysis